PDB: 1008 resultsInfo pagesStatus searchChemie searchBIRD

---

6E5E	Crystal structure of the apo domain-swapped dimer Q108K:T51D mutant of human cellular retinol binding protein II Descriptor: ACETATE ION, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.696 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E5Q	Crystal structure of the apo domain-swapped dimer Q108K:T51D:A28H mutant of human Cellular Retinol Binding Protein II Descriptor: ACETATE ION, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-21 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.99 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E7M	Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:T51D:A28C mutant of human Cellular Retinol Binding Protein II Descriptor: ACETATE ION, GLYCEROL, RETINAL, ... Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-26 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.7 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6MCU	Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:T51D:A28H mutant of human Cellular Retinol Binding Protein II Descriptor: GLYCEROL, RETINAL, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-09-02 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.572 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6ON7	Crystal Structure of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.981 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E6L	Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:K40L:T51F:Y60A mutant of human cellular retinol binding protein II Descriptor: ACETATE ION, RETINAL, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-25 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.08 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6MCV	Crystal Structure of Holo Retinal-Bound Domain-Swapped Dimer of Wild Type Human Cellular Retinol Binding Protein II Descriptor: RETINAL, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-09-02 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (3.3 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6MKV	Crystal structure of Retinal-bound holo Q108K:K40L:T51W domain-swapped dimer of human cellular retinol binding protein 2 Descriptor: ACETATE ION, GLYCEROL, RETINAL, ... Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-09-26 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.107 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6MLB	Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:K40L:T51F mutant of human cellular retinol binding protein II Descriptor: ACETATE ION, GLYCEROL, RETINAL, ... Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-09-27 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.15 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6T44	Ovine lactoglobulin complex with decanol Descriptor: Beta-lactoglobulin-1/B, DECAN-1-OL Authors: Loch, J.I, Kopec, M, Lewinski, K. Deposit date: 2019-10-12 Release date: 2019-10-23 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Conformational flexibility and ligand binding properties of ovine beta-lactoglobulin. Acta Biochim.Pol., 66, 2019
6T42	Bovine lactoglobulin complex with decanol Descriptor: Beta-lactoglobulin, DECAN-1-OL Authors: Loch, J.I, Kopec, M, Lewinski, K. Deposit date: 2019-10-11 Release date: 2019-10-23 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.95 Å) Cite: Conformational flexibility and ligand binding properties of ovine beta-lactoglobulin. Acta Biochim.Pol., 66, 2019
6XVE	Engineered beta-lactoglobulin: variant F105L Descriptor: Beta-lactoglobulin Authors: Loch, J.I, Gotkowski, M, Lewinski, K. Deposit date: 2020-01-21 Release date: 2020-01-29 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.15 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6S8V	Structure of the high affinity Anticalin P3D11 in complex with the human CD98 heavy chain ectodomain Descriptor: 1,2-ETHANEDIOL, 4F2 cell-surface antigen heavy chain, Neutrophil gelatinase-associated lipocalin Authors: Schiefner, A, Deuschle, F.-C, Skerra, A. Deposit date: 2019-07-10 Release date: 2020-03-04 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Development of a high affinity Anticalin®directed against human CD98hc for theranostic applications. Theranostics, 10, 2020
6XVS	Human myelin protein P2 mutant P38G, unliganded Descriptor: GLYCEROL, Myelin P2 protein Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XUW	Human myelin protein P2 mutant L27D Descriptor: CHLORIDE ION, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-21 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.31 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVQ	Human myelin protein P2 mutant K31Q Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVY	Human myelin protein P2 mutant R88Q Descriptor: CHLORIDE ION, CITRIC ACID, Myelin P2 protein, ... Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XU5	Human myelin protein P2 mutant N2D Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.65 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6STS	Human myelin protein P2 mutant R30Q Descriptor: Myelin P2 protein, PALMITIC ACID, SULFATE ION Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2019-09-11 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (3 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XUA	Human myelin protein P2 mutant K21Q Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.3 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XW9	Human myelin protein P2 mutant K120S Descriptor: CHLORIDE ION, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-23 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.9 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XU9	Human myelin protein P2 mutant K3N Descriptor: CHLORIDE ION, CITRIC ACID, Myelin P2 protein, ... Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.7 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVR	Human myelin protein P2 mutant L35S Descriptor: Myelin P2 protein, PALMITIC ACID, SULFATE ION Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6LJU	Crystal structure of human FABP4 in complex with a novel inhibitor Descriptor: 1,2-ETHANEDIOL, 2-[[3-chloranyl-4-(methylamino)-2-phenyl-phenyl]amino]benzoic acid, Fatty acid-binding protein, ... Authors: Su, H.X, Zhang, X.L, Li, M.J, Xu, Y.C. Deposit date: 2019-12-17 Release date: 2020-04-15 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.5 Å) Cite: Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J.Med.Chem., 63, 2020
6LJX	Crystal structure of human FABP4 in complex with a novel inhibitor Descriptor: 2-phenylazanylbenzoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Zhang, X.L, Li, M.J, Xu, Y.C. Deposit date: 2019-12-17 Release date: 2020-04-15 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.75 Å) Cite: Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J.Med.Chem., 63, 2020

<18192021222324252627282930313233>